RCT
Rubius Therapeutics, Inc.
Application Filed: 2017-01-03
Trademark Application Details
THIRD EXTENSION - GRANTED
| Research |
OneLook
Acronym Finder
|
| Serial Number | 87287749 |
| Registration Number | 6315836 |
| Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
| Attorney Name | Christina M. Licursi |
| Attorney Docket Number | R076520004US |
| Law Office Assigned | L50 |
| Employee Name | VALLILLO, MELISSA C |
Timeline
| 2017-01-03 | Application Filed |
| 2017-11-28 | Published for Opposition |
| 2018-01-23 | Location: INTENT TO USE SECTION |
| 2019-07-23 | Status: Live/Pending |
| 2019-07-25 | Transaction Date |
| 2021-04-06 | Trademark Registered |
Trademark Applicants & Owners
| Owner: |  Rubius Therapeutics, Inc. |
| Address | 399 Binney Street Cambridge DE 02139 |
| Legal Entity Type | Corporation |
| Legal Entity State | DE |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Attorney of Record
Good, Services, and Codes
| International Codes: | 5 |
| U.S. Codes: | 006,018,044,046,051,052 |
| International Codes: | 42 |
| U.S. Codes: | 100,101 |
| Type Code | Type |
|---|---|
| GS0051 | Cells for medical or clinical use for the treatment of a variety of human and animal diseases and conditions, namely, cancer, inflammatory diseases and disorders, autoimmune diseases and disorders, metabolic diseases and disorders, genetic diseases and disorders, infectious diseases and disorders, cardiovascular diseases and disorders; pharmaceutical preparations of engineered eythroid cells for medical or clinical use for the treatment of a variety of human and animal diseases and conditions, namely, cancer, inflammatory diseases and disorders, autoimmune diseases and disorders, metabolic diseases and disorders, genetic diseases and disorders, infectious diseases and disorders, cardiovascular diseases and disorders; engineered erythroid cells for medical or clinical use for the treatment of a variety of a variety of human and animal diseases and conditions, namely, cancer, inflammatory diseases and disorders, autoimmune diseases and disorders, metabolic diseases and disorders, genetic diseases and disorders, infectious diseases and disorders, cardiovascular diseases and disorders, none of the foregoing related chemical research, research services in connection with physics and engineering research, or to photovoltaic installations |
| GS0051 | Cells for medical or clinical use for the treatment of a variety of human and animal diseases and conditions, namely, cancer, inflammatory diseases and disorders, autoimmune diseases and disorders, metabolic diseases and disorders, genetic diseases and disorders, infectious diseases and disorders, cardiovascular diseases and disorders; pharmaceutical preparations of engineered eythroid cells for medical or clinical use for the treatment of a variety of human and animal diseases and conditions, namely, cancer, inflammatory diseases and disorders, autoimmune diseases and disorders, metabolic diseases and disorders, genetic diseases and disorders, infectious diseases and disorders, cardiovascular diseases and disorders; engineered erythroid cells for medical or clinical use for the treatment of a variety of a variety of human and animal diseases and conditions, namely, cancer, inflammatory diseases and disorders, autoimmune diseases and disorders, metabolic diseases and disorders, genetic diseases and disorders, infectious diseases and disorders, cardiovascular diseases and disorders, none of the foregoing related chemical research, research services in connection with physics and engineering research, or to photovoltaic installations |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2017-01-12 | 1 NWOS I:Incoming Correspondence |
| ASSIGNED TO EXAMINER | 2017-03-28 | 2 DOCK D:Assigned to Examiner |
| NON-FINAL ACTION WRITTEN | 2017-04-04 | 3 CNRT R:Renewal |
| NON-FINAL ACTION E-MAILED | 2017-04-04 | 4 GNRT F:First Action |
| NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2017-04-04 | 5 GNRN O:Outgoing Correspondence |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2017-09-29 | 6 TROA I:Incoming Correspondence |
| ASSIGNED TO LIE | 2017-10-12 | 7 ALIE A:Allowance for Publication |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2017-10-16 | 8 CRFA I:Incoming Correspondence |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2017-10-16 | 9 TEME I:Incoming Correspondence |
| EXAMINERS AMENDMENT -WRITTEN | 2017-10-20 | 10 CNEA R:Renewal |
| EXAMINERS AMENDMENT E-MAILED | 2017-10-20 | 11 GNEA O:Outgoing Correspondence |
| NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | 2017-10-20 | 12 GNEN O:Outgoing Correspondence |
| EXAMINER'S AMENDMENT ENTERED | 2017-10-20 | 13 XAEC I:Incoming Correspondence |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2017-10-20 | 14 CNSA P: |
| LAW OFFICE PUBLICATION REVIEW COMPLETED | 2017-10-26 | 15 PREV O:Outgoing Correspondence |
| NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2017-11-08 | 16 NONP E:E-Mail |
| PUBLISHED FOR OPPOSITION | 2017-11-28 | 17 PUBO A:Allowance for Publication |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2017-11-28 | 18 NPUB E:E-Mail |
| NOA E-MAILED - SOU REQUIRED FROM APPLICANT | 2018-01-23 | 19 NOAM E:E-Mail |
| TEAS CHANGE OF OWNER ADDRESS RECEIVED | 2018-05-02 | 20 COAR I:Incoming Correspondence |
| APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | 2018-05-02 | 21 CHAN I:Incoming Correspondence |
| TEAS EXTENSION RECEIVED | 2018-07-20 | 22 EEXT I:Incoming Correspondence |
| EXTENSION 1 FILED | 2018-07-20 | 23 EXT1 S: |
| EXTENSION 1 GRANTED | 2018-07-20 | 24 EX1G S: |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2018-07-24 | 25 EXRA E:E-Mail |
| TEAS EXTENSION RECEIVED | 2019-01-23 | 26 EEXT I:Incoming Correspondence |
| EXTENSION 2 FILED | 2019-01-23 | 27 EXT2 S: |
| EXTENSION 2 GRANTED | 2019-01-23 | 28 EX2G S: |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2019-01-25 | 29 EXRA E:E-Mail |
| TEAS CHANGE OF OWNER ADDRESS RECEIVED | 2019-02-06 | 30 COAR I:Incoming Correspondence |
| APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | 2019-02-06 | 31 CHAN I:Incoming Correspondence |
| TEAS EXTENSION RECEIVED | 2019-07-23 | 32 EEXT I:Incoming Correspondence |
| EXTENSION 3 FILED | 2019-07-23 | 33 EXT3 S: |
| EXTENSION 3 GRANTED | 2019-07-23 | 34 EX3G S: |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2019-07-25 | 35 EXRA E:E-Mail |
| TEAS STATEMENT OF USE RECEIVED | 2020-01-23 | 36 EISU I:Incoming Correspondence |
| TEAS EXTENSION RECEIVED | 2020-01-23 | 37 EEXT I:Incoming Correspondence |
| CASE ASSIGNED TO INTENT TO USE PARALEGAL | 2020-01-28 | 38 AITU A:Allowance for Publication |
| EXTENSION 4 FILED | 2020-01-23 | 39 EXT4 S: |
| EXTENSION 4 GRANTED | 2020-01-28 | 40 EX4G S: |
| USE AMENDMENT FILED | 2020-01-23 | 41 IUAF S: |
| STATEMENT OF USE PROCESSING COMPLETE | 2020-01-28 | 42 SUPC I:Incoming Correspondence |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2020-01-29 | 43 EXRA E:E-Mail |
| SU - NON-FINAL ACTION - WRITTEN | 2020-02-13 | 44 CNRT W: |
| NON-FINAL ACTION E-MAILED | 2020-02-13 | 45 GNRT O:Outgoing Correspondence |
| NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2020-02-13 | 46 GNRN O:Outgoing Correspondence |
| ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | 2020-09-02 | 47 ABN2 O:Outgoing Correspondence |
| ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND | 2020-09-03 | 48 MAB2 E:E-Mail |
| REINSTATEMENT GRANTED - INADVERTENTLY ABANDONED | 2020-09-08 | 49 RGIA O:Outgoing Correspondence |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2020-08-13 | 50 TROA I:Incoming Correspondence |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2020-08-13 | 51 CRFA I:Incoming Correspondence |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2020-09-09 | 52 TEME I:Incoming Correspondence |
| NOTICE OF REINSTATEMENT E-MAILED | 2020-09-11 | 53 MREI E:E-Mail |
| SU - FINAL REFUSAL - WRITTEN | 2020-09-30 | 54 CNFR W: |
| FINAL REFUSAL E-MAILED | 2020-09-30 | 55 GNFR O:Outgoing Correspondence |
| NOTIFICATION OF FINAL REFUSAL EMAILED | 2020-09-30 | 56 GNFN O:Outgoing Correspondence |
| TEAS REQUEST FOR RECONSIDERATION RECEIVED | 2021-02-18 | 57 ERFR I:Incoming Correspondence |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2021-02-18 | 58 CRFA I:Incoming Correspondence |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2021-02-19 | 59 TEME I:Incoming Correspondence |
| ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | 2021-03-02 | 60 CNPR P: |
| NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | 2021-03-03 | 61 SUNA E:E-Mail |
| REGISTERED-PRINCIPAL REGISTER | 2021-04-06 | 62 R.PR A:Allowance for Publication |
Similar Marks
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 